Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Allergan Plc (AGN)

Allergan Plc (AGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 63,503,972
  • Shares Outstanding, K 329,002
  • Annual Sales, $ 16,089 M
  • Annual Income, $ -5,271 M
  • 60-Month Beta 1.20
  • Price/Sales 3.95
  • Price/Cash Flow 5.26
  • Price/Book 1.09
Trade AGN with:
  • Price/Earnings ttm 10.94
  • Earnings Per Share ttm 17.64
  • Most Recent Earnings 5.22 on 02/10/20
  • Next Earnings Date 05/07/20
  • Annual Dividend & Yield 2.96 (0.00%)
  • Most Recent Dividend 0.740 on 04/15/20
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 4.24
  • Number of Estimates 1
  • High Estimate 4.24
  • Low Estimate 4.24
  • Prior Year 3.79
  • Growth Rate Est. (year over year) +11.87%

Price Performance

See More
Period Period Low Period High Performance
1-Month
181.21 +6.52%
on 04/09/20
196.45 -1.75%
on 05/06/20
+11.94 (+6.59%)
since 04/08/20
3-Month
158.67 +21.65%
on 03/18/20
202.21 -4.55%
on 02/12/20
-4.03 (-2.05%)
since 02/07/20
52-Week
114.27 +68.92%
on 06/17/19
202.21 -4.55%
on 02/12/20
+52.97 (+37.82%)
since 05/08/19

Most Recent Stories

More News
Ophthalmology Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030

Reportlinker.com announces the release of the report "Ophthalmology Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030" - https://www.reportlinker.com/p06027742/?utm_source=GNW

AGN : 193.02 (+0.02%)
NVS : 85.91 (-0.92%)
Gastrointestinal Drugs Global Market Report 2021: COVID 19 Implications and Growth to 2030

Reportlinker.com announces the release of the report "Gastrointestinal Drugs Global Market Report 2021: COVID 19 Implications and Growth to 2030" - https://www.reportlinker.com/p06027759/?utm_source=GNW...

AGN : 193.02 (+0.02%)
AZN : 48.38 (-1.08%)
NVO : 71.25 (-1.51%)
Allergan, an AbbVie Company, Submits New Drug Application for Investigational AGN-190584 for the Treatment of Presbyopia

, /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration for investigational AGN-190584 (pilocarpine...

AGN : 193.02 (+0.02%)
ABBV : 107.74 (+0.38%)
Intravitreal (IVT) Injectables Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027

The Global is poised to register a CAGR of over 4.7% during the forecast period 2020 to 2027.

ALIM : 8.07 (+1.51%)
AGN : 193.02 (+0.02%)
NVS : 85.91 (-0.92%)
REGN : 450.57 (-0.58%)
VRX.TO : 30.80 (-3.33%)
Worldwide Cephalosporin Industry to 2026 - by Generation, Route of Administration, Application and Region

, /PRNewswire/ -- The report has been added to offering.

AGN : 193.02 (+0.02%)
BMY : 61.33 (-1.24%)
GSK : 33.61 (-2.24%)
MRK : 72.62 (-2.68%)
NVS : 85.91 (-0.92%)
PFE : 33.49 (-0.98%)
TEVA : 10.76 (-2.18%)
Medical Aesthetics Market Research Report Including SWOT Analysis, PESTEL Analysis, Drivers, Restraints, Global Industry Outlook and Key Players Analysis By 2027

The scope of the report includes a detailed study of global and regional markets on Global Medical Aesthetics Market with the reasons given for variations in the growth of the industry in certain regions....

AGN : 193.02 (+0.02%)
CYNO : 66.15 (+0.23%)
NSRGY : 104.8200 (-0.31%)
ELOS : 11.00 (unch)
VRX.TO : 30.80 (-3.33%)
ZLTQ : 56.48 (unch)
Outlook on the Cephalosporin Global Market to 2026 - Players Include Allergan, GlaxoSmithKline and Lupin Among Others

The "Cephalosporin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

AGN : 193.02 (+0.02%)
GSK : 33.61 (-2.24%)
Dermal Fillers Market Size Worth USD 6899.16 Million By 2025 at 13.2% CAGR | Growing Awareness about Invasive-Free Techniques to Boost Global Industry, Says Market Research Future (MRFR)

Dermal Fillers Market Overview:

AGN : 193.02 (+0.02%)
Global Anti-Aging Market (2021 to 2026) - Featuring Allergan, Beiersdorf & Unilever Among Others - ResearchAndMarkets.com

The "Global Anti-Aging Market Report and Forecast (2021-2026)" report has been added to ResearchAndMarkets.com's offering.

AGN : 193.02 (+0.02%)
Ophthalmic Steroids Drug Market 2020 Size, Share, Current trends, Competitive Analysis and Forecast to 2027 |Ameco Research

pune, India, Mon, 22 Feb 2021 04:57:12 / Comserve Inc. / -- Ophthalmic Steroids Drugs refer to the steroids drug for the Ophthalmic. A large class of important natural compounds is derived from steroids...

ALIM : 8.07 (+1.51%)
AGN : 193.02 (+0.02%)
BAYRY : 15.3000 (-2.65%)
GSK : 33.61 (-2.24%)
NVS : 85.91 (-0.92%)
REGN : 450.57 (-0.58%)
VRX.TO : 30.80 (-3.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 194.42
1st Resistance Point 193.72
Last Price 193.02
1st Support Level 191.98
2nd Support Level 190.94
3rd Support Level N/A

See More

52-Week High 202.21
Last Price 193.02
Fibonacci 61.8% 168.62
Fibonacci 50% 158.24
Fibonacci 38.2% 147.86
52-Week Low 114.27

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar